Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
RespiDx
RespiDx Overview
RespiDx is a social impact venture that has developed the Multimometer, a device designed to enable simple diagnosis of pneumonia and febrile disease in the field by untrained community health workers. The automatic diagnosis of pneumonia is based on World Health Organization diagnostic criteria.
RespiDxs efforts are currently focused on optimizing the companys pneumonia diagnosis device for mass manufacturing and market entry. Clinical studies of the Multimometer have been performed in the Democratic Republic of the Congo.
RespiDxs activities in diagnosing pneumonia in underdeveloped countries are supported by Grand Challenges Israel, USAid, and Grand Challenges Canada.